JT Stratford LLC’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.36M Buy
11,374
+238
+2% +$70.7K 0.43% 56
2025
Q4
$3.04M Buy
11,136
+6,674
+150% +$1.81M 0.39% 60
2025
Q3
$1.21M Sell
4,462
-52
-1% -$14.1K 0.16% 125
2025
Q2
$1.24M Buy
4,514
+3
+0.1% +$816 0.19% 127
2025
Q1
$1.2M Sell
4,511
-3,375
-43% -$833K 0.21% 120
2024
Q4
$1.83M Sell
7,886
-346
-4% -$79.6K 0.3% 79
2024
Q3
$1.82M Buy
8,232
+1,052
+15% +$218K 0.31% 71
2024
Q2
$1.41M Sell
7,180
-1,152
-14% -$238K 0.26% 88
2024
Q1
$1.79M Buy
8,332
+31
+0.4% +$6.51K 0.36% 77
2023
Q4
$1.75M Sell
8,301
-3,377
-29% -$721K 0.4% 61
2023
Q3
$2.34M Buy
11,678
+1,542
+15% +$307K 0.6% 33
2023
Q2
$1.88M Sell
10,136
-1,909
-16% -$353K 0.51% 50
2023
Q1
$2.31M Buy
12,045
+6,688
+125% +$1.21M 0.66% 36
2022
Q4
$901K Buy
+5,357
New +$931K 0.29% 94
2019
Q1
Sell
-1,665
Closed -$313K 123
2018
Q4
$313K Buy
+1,665
New +$307K 0.21% 80

Other funds holding CME

JT Stratford LLC's CME Position: Q1 2026 in Review

JT Stratford LLC increased its CME Group (CME) stake by 2.1% in Q1 2026, buying an estimated $70.7K and bringing the position to 11,374 shares worth $3.36M. The position accounts for 0.43% of the portfolio, ranked #56.

JT Stratford LLC first reported a position in CME in Q4 2018 and has held it in 15 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • JT Stratford LLC held 11,374 shares of CME Group worth $3.36M as of Q1 2026.
  • JT Stratford LLC bought 238 CME Group shares in Q1 2026, an estimated $70.7K.
  • CME Group made up 0.43% of JT Stratford LLC's portfolio in Q1 2026, its #56 holding.
  • JT Stratford LLC first reported a position in CME Group in Q4 2018 and has held it in 15 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on JT Stratford LLC's 13F filing for Q1 2026, filed 15 May 2026.